Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.47 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11294092 | 0.85 | TDP1 (0.51) | ALDH1A1MAPTLMNAPTGS2HPGD | |
| SCHEMBL22558457 | 0.84 | ALDH1A1 (0.53) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| SCHEMBL9547096 | 0.83 | ADRB2 (0.45) | ALDH1A1KMT2AMAPTLMNAPOLB | |
| SCHEMBL29575610 | 0.81 | KMT2A (0.48) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| SCHEMBL9598330 | 0.80 | ALDH1A1 (0.50) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| SCHEMBL6937180 | 0.80 | KMT2A (0.55) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| SCHEMBL346667 | 0.79 | HTT (0.59) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| SCHEMBL28566928 | 0.79 | KMT2A (0.46) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| SCHEMBL10684102 | 0.79 | MEN1 (0.49) | ALDH1A1KMT2AMEN1MAPTKEAP1 | |
| SCHEMBL21618283 | 0.78 | ALDH1A1 (0.44) | ALDH1A1KMT2AMEN1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0011460-B1 | PEROXYGEN BLEACHING AND COMPOSITIONS THEREFOR | FMC Corporation (US) | 1982-09-29 | — | — | EP | claimed |
| EP-0011460-A1 | Peroxygen bleaching and compositions therefor | FMC Corporation (US) | 1980-05-28 | — | — | EP | claimed |
| US-20230284471-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-09-07 | — | — | US | disclosed |
| US-11542270-B2 | BCKDK inhibitors | PFIZER INC. (US) | 2023-01-03 | — | — | US | disclosed |
| US-20210024536-A1 | BCKDK INHIBITORS | PFIZER INC. (US) | 2021-01-28 | — | — | US | disclosed |
| US-9983476-B2 | Resin composition including novel polymer and organic film using the same | SAMSUNG SDI CO., LTD. (KR) | 2018-05-29 | — | — | US | disclosed |
| US-20170139323-A1 | Resin Composition Including Novel Polymer and Organic Film Using the Same | SAMSUNG SDI CO., LTD. (KR) | 2017-05-18 | — | — | US | disclosed |
| EP-1581467-B1 | LIGANDS FOR METALS AND IMPROVED METAL-CATALYZED PROCESSES BASED THEREON | MASSACHUSETTS INST TECHNOLOGY (US) | 2016-10-12 | — | — | EP | disclosed |
| EP-2583958-B1 | Ligands for metals and improved metal-catalyzed processes based thereon | MASSACHUSETTS INST TECHNOLOGY (US) | 2016-08-10 | — | — | EP | disclosed |
| EP-2173716-B1 | A PROCESS FOR THE PALLADIUM-CATALYZED COUPLING OF TERMINAL ALKYNES WITH HETEROARYL TOSYLATES AND HETEROARYL BENZENESULFONATES | SANOFI SA (FR) | 2014-03-19 | — | — | EP | disclosed |
| CN-101687796-B | Palladium-catalyzed coupling reaction of terminal alkynes with heteroaryltosylates and heteroarylbenzenesulfonates | SANOFI AVENTIS SPA | 2013-08-14 | — | — | CN | disclosed |
| EP-1167372-B1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | TAKASAGO PERFUMERY CO LTD (JP) | 2003-12-10 | — | — | EP | disclosed |
| US-6455720-B1 | AS CATALYSTS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-09-24 | — | — | US | disclosed |
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-05-16 | — | — | US | disclosed |
| US-6365776-B1 | FROM ORGANOHALOGEN COMPOUND AND AMINE USING PALLADIUM COMPOUND CATALYST AND PROMOTER | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-04-02 | — | — | US | disclosed |
| US-20020035295-A1 | PROCESS FOR PRODUCING AROMATIC AMINES | TAKASAGO INTERNATIONAL CORPORATION | 2002-03-21 | — | — | US | disclosed |
| EP-1167372-A1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | Takasago International Corporation (JP) | 2002-01-02 | — | — | EP | disclosed |
| EP-0011460-B1 | PEROXYGEN BLEACHING AND COMPOSITIONS THEREFOR | FMC Corporation (US) | 1982-09-29 | — | — | EP | disclosed |
| US-4215003-A | INCLUDING HETEROCYCLIC SULFONATE ESTERS OF AN ALKANE- OR ARYLSULFONIC ACID AS ACTIVATORS; LOW TEMPERATURE | FMC CORPORATION (US) | 1980-07-29 | — | — | US | disclosed |
| EP-0011460-A1 | Peroxygen bleaching and compositions therefor | FMC Corporation (US) | 1980-05-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035295-A1 | PROCESS FOR PRODUCING AROMATIC AMINES | TYR, DDC, PNMT | ALDH1A1 1669/4885KMT2A 359/4885MEN1 1606/4885 |
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | DDT, PDCD11, PLD2 | ALDH1A1 2369/4885KMT2A 170/4885MEN1 2881/4885 |
| US-11542270-B2 | BCKDK inhibitors | BCKDK, PDK4, PDK3 | ALDH1A1 272/4885KMT2A 2155/4885MEN1 4252/4885 |
| US-20210024536-A1 | BCKDK INHIBITORS | BCKDK, PDK4, PDK3 | ALDH1A1 272/4885KMT2A 2155/4885MEN1 4252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.